Physician

Anthony Vincent Songco, M.D.

According to 2025 Medicare claims, Anthony Songco, M.D. (NPI: 1508025909) practices interventional cardiology in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is PROMEDICA NORTHWEST OHIO CARDIOLOGY CONSULTANTS, LLC (NPI: 1780820555; TIN: 263888045) and primary practice location at 48162-7815. Songco is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Songco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 927 traditional Medicare patients, billed 2,077 HCPCS/CPT codes, and received $128,945 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,690 prescription claims across 628 beneficiaries totaling $438,392 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 12 claims. Open Payments data shows 44 records totaling $850. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $81,296 to $438,392. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,255	2,736	$176,738
2016	1,199	3,011	$191,985
2017	1,373	3,183	$172,951
2018	1,276	3,141	$163,319
2019	1,143	3,058	$205,877
2020	1,164	3,039	$181,050
2021	1,033	2,553	$169,335
2022	1,072	2,470	$151,150
2023	931	2,095	$131,456
2024	927	2,077	$128,945

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	330	1,326	$81,296
2016	350	2,342	$142,344
2017	430	2,983	$285,016
2018	501	2,691	$224,268
2019	583	2,880	$271,575
2020	585	2,708	$275,315
2021	643	2,665	$214,662
2022	652	2,586	$326,837
2023	619	2,596	$418,473
2024	628	2,690	$438,392

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$49,442
2019	N/R	17	$36,940
2020	N/R	12	$23,686
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	226	280	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	291	336	$60
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	133	133	$57
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	114	114	$10
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	303	311	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	198	11,829	$220,323
Xarelto	Rivaroxaban	47	2,520	$45,022
Jardiance	Empagliflozin	30	2,100	$36,994
Entresto	Sacubitril/Valsartan	33	1,710	$36,508
Farxiga	Dapagliflozin Propanediol	28	1,590	$27,497

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$850	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Vincent Songco, M.D.?

Tedicare shows public-source Medicare data for Anthony Vincent Songco, M.D. (NPI 1508025909), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Vincent Songco, M.D. have ACO affiliation data?

Anthony Vincent Songco, M.D. is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Anthony Vincent Songco, M.D.?

Anthony Vincent Songco, M.D. is linked to PROMEDICA NORTHWEST OHIO CARDIOLOGY CONSULTANTS, LLC (billing NPI 1780820555) in the available physician profile data.

Does Anthony Vincent Songco, M.D. have Open Payments data?

Anthony Vincent Songco, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.